Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,093 | 44,229 | 74,696 | 76,322 | 61,486 |
| Marketable Securities | 68,387 | 68,148 | 53,227 | 52,215 | 54,151 |
| Receivables | 11,552 | 6,933 | 5,614 | 4,077 | 3,273 |
| Inventories | 1,181 | 1,222 | 1,130 | 894 | 534 |
| Other current assets | 0 | 0 | 0 | 0 | 30 |
| TOTAL | $126,002 | $124,504 | $139,319 | $136,987 | $121,036 |
| Non-Current Assets | |||||
| PPE Net | 1,718 | 1,532 | 1,600 | 1,387 | 1,481 |
| Other Non-Current Assets | 28,341 | 30,122 | 31,865 | 735 | 652 |
| TOTAL | $30,059 | $31,654 | $33,465 | $2,122 | $2,133 |
| Total Assets | $156,061 | $156,158 | $172,784 | $139,109 | $123,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,661 | 3,777 | 1,179 | 6,391 | 2,641 |
| Accrued Expenses | 12,697 | 11,310 | 11,431 | 16,715 | 13,300 |
| TOTAL | $31,006 | $28,380 | $26,138 | $27,734 | $19,696 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,789 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 1,587 | 1,362 | 1,532 | 1,030 | N/A |
| Other Non-Current Liabilities | 21,179 | 23,086 | 24,950 | 0 | 0 |
| TOTAL | $56,144 | $49,487 | $51,331 | $1,498 | $N/A |
| Total Liabilities | $87,150 | $77,867 | $77,469 | $29,232 | $19,696 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,761 | 16,761 | 16,719 | 16,717 | 16,664 |
| Common Shares | 168 | 168 | 167 | 167 | 166 |
| Retained earnings | -1,259,028 | -1,247,538 | -1,226,932 | -1,209,334 | -1,212,562 |
| Other shareholders' equity | 36 | 43 | 10 | -24 | -25 |
| TOTAL | $68,911 | $78,291 | $95,315 | $109,877 | $103,473 |
| Total Liabilities And Equity | $156,061 | $156,158 | $172,784 | $139,109 | $123,169 |